CURE Honors World Ovarian Cancer Day

Jessica Skarzynski
Jessica Skarzynski

Today is World Ovarian Cancer Day, and in honor of this day that was created in 2013 to raise awareness about the disease, CURE® is rounding up the latest news and updates in this cancer space.

In honor of World Ovarian Cancer Day, which was created in 2013 to raise awareness about the disease, CURE® rounded up the latest news and updates in this cancer space:

  • In this episode of the “CURE® Talks Cancer” podcast, we spoke with an ovarian cancer survivor and teacher about how she maintained her sense of humor through treatment and why it’s important to remain connected to friends and family, especially during the darkest moments.

  • Following chemotherapy with secondary cytoreduction for patients with platinum-sensitive relapsed ovarian cancer contributed to longer progression-free survival compared with chemotherapy alone, according to study results published in The Lancet Oncology.

  • Maintenance therapy with a PARP inhibitor demonstrated benefits including progression-free survival for those with high-grade, recurrent, platinum-sensitive ovarian cancer, according to data published in Cancer.

  • Fertility treatments led to an ovarian cancer diagnosis but also opened the door to adoption and a new view on life for Elizabeth Johnston, who shared her story with us in our latest Women’s Cancers Special Issue.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.